Baker Aaron R, Fanelli David G, Kanekar Sangam, Isildak Huseyin
*Department of Surgery, Division of Otolaryngology-Head and Neck Surgery †College of Medicine ‡Department of Radiology, College of Medicine, The Pennsylvania State University, Hershey, Pennsylvania.
Otol Neurotol. 2017 Jan;38(1):86-88. doi: 10.1097/MAO.0000000000001235.
Current bone-anchored hearing aid (BAHA) guidelines recommend placement of the titanium implant 5 to 7 cm posterior to the ear canal. Previous studies show that bone conducted hearing is maximized the closer the transducer is to the cochlea. We aim to investigate the position of the sigmoid sinus with respect to BAHA implants to determine whether they may be safely placed closer to the ear canal in patients with chronic ear disease, enhancing the amplification available to the patient.
We performed a retrospective review of high-resolution temporal bone computed tomographies (CTs), comparing multiple measurements between ears with chronic ear disease and normal controls.
Images were obtained at a single academic medical center.
Eighty patients (160 ears) with temporal bone CTs performed between 2006 and 2009 were measured. Patients with chronic ear disease were identified by international statistical classification of diseases and related health problems, revision 9 code and confirmation by review of the imaging.
Measurements were made on axial CT slices from a point 1 cm posterior to the sigmoid sinus to the posterior margin of the external canal. The squamous temporal bone thickness was also measured at this point.
Forty-seven patients (55 ears) had chronic ear disease. Distance from the posterior canal was significantly different between normal and diseased ears (36.3 mm versus 33.5 mm, p < 0.001). Squamous temporal bone thickness varied widely, and was similar between groups (6.9 mm versus 6.8 mm, p = 0.76).
According to our data, titanium implants for bone-anchored hearing aids may be safely placed closer to the external canal than the current recommendations. This could allow for better transduction as well as sound localization in BAHA patients.
当前骨锚式助听器(BAHA)指南建议将钛植入体放置在耳道后方5至7厘米处。先前的研究表明,换能器离耳蜗越近,骨传导听力效果越好。我们旨在研究乙状窦相对于BAHA植入体的位置,以确定在慢性耳部疾病患者中,是否可以将植入体更安全地放置在离耳道更近的位置,从而增强患者可获得的放大效果。
我们对高分辨率颞骨计算机断层扫描(CT)进行了回顾性研究,比较了慢性耳部疾病患者与正常对照组双耳之间的多项测量结果。
图像在单一学术医疗中心获取。
对2006年至2009年间进行颞骨CT检查的80例患者(160只耳)进行了测量。通过国际疾病和相关健康问题统计分类第9版编码以及影像学复查来确定慢性耳部疾病患者。
在轴向CT切片上进行测量,从乙状窦后方1厘米处的点至外耳道后缘。同时在此点测量颞骨鳞部厚度。
47例患者(55只耳)患有慢性耳部疾病。正常耳与患病耳到外耳道后方的距离存在显著差异(36.3毫米对33.5毫米,p<0.001)。颞骨鳞部厚度差异较大,两组之间相似(6.9毫米对6.8毫米,p=0.76)。
根据我们的数据,用于骨锚式助听器的钛植入体可以比当前建议更安全地放置在离外耳道更近的位置。这可以在BAHA患者中实现更好的换能以及声音定位。